AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18471341 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 16311286 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 50 mg in saline 0.9% w/v, 500 ml at 999 ml h(‐1)
Number of subjects: 2
Study 16311286 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 500 microg in saline 0.9% w/v, 500 ml at 999 ml h(‐1)
Number of subjects: 2
Study 12559808 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaxigrip
Number of subjects: 2150
Study 12559808 — intervention group
Group type: COMPARATOR
Intervention: Fluad
Number of subjects: 2150
Study 12559808 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 2150
Study 10810841 — intervention group
Group type: EXPERIMENTAL
Intervention: Written statements of expert witnesses provided before testimony
Number of subjects: 0
Study 10810841 — intervention group
Group type: EXPERIMENTAL
Intervention: Written statements of expert witnesses provided after testimony
Number of subjects: 0
Study 10810841 — intervention group
Group type: COMPARATOR
Intervention: No written statements of expert witnesses
Number of subjects: 0
Study 8856257 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis with dialysate containing 128 mEq/l sodium
Number of subjects: 22
Study 8856257 — intervention group
Group type: COMPARATOR
Intervention: Dialysis with dialysate containing 137 mEq/l sodium
Number of subjects: 22
Study 1520833 — intervention group
Group type: EXPERIMENTAL
Intervention: GORE-TEX
Number of subjects: 17
Study 1520833 — intervention group
Group type: EXPERIMENTAL
Intervention: Marlex
Number of subjects: 17
Study 6527754 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg brotizolam
Number of subjects: 29
Study 6527754 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg nitrazepam
Number of subjects: 29
Study 6527754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31552750 — intervention group
Group type: EXPERIMENTAL
Intervention: 5F ureteral stent
Number of subjects: 110
Study 31552750 — intervention group
Group type: COMPARATOR
Intervention: 6F ureteral stent
Number of subjects: 110
Study 30148660 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 136
Study 30148660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 30148660 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with ADHD (no medication)
Number of subjects: 136
Study 26447193 — intervention group
Group type: EXPERIMENTAL
Intervention: Guaranteed pay‐out (GPO) incentives
Number of subjects: 36
Study 26447193 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentives
Number of subjects: 36
Study 26447193 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 36
Study 24467861 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning‐Centered Group Psychotherapy (MCGP‐CS)
Number of subjects: 168
Study 24467861 — intervention group
Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 168
Study 24467861 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 168
Study 21247745 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (after one-week treatment)
Number of subjects: 10
Study 20545786 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsweetened ice-popsicle
Number of subjects: 31
Study 20545786 — intervention group
Group type: COMPARATOR
Intervention: Toy
Number of subjects: 31
Study 18282613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue (Quixil, OMRIX biopharmaceuticals) applied to tonsillar beds at the end of the operation
Number of subjects: 168
Study 18282613 — intervention group
Group type: COMPARATOR
Intervention: Control group (tonsillectomy without fibrin glue)
Number of subjects: 168
Study 15988705 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 95
Study 15988705 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/d
Number of subjects: 95
Study 15988705 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of raloxifene 60 mg/d and simvastatin 10 mg/d
Number of subjects: 95
Study 15988705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 12028719 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated display
Number of subjects: 39
Study 12028719 — intervention group
Group type: COMPARATOR
Intervention: Functionally-separate display
Number of subjects: 39
Study 12028719 — intervention group
Group type: COMPARATOR
Intervention: Spatially-separate display
Number of subjects: 39
Study 12028719 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex scenarios
Number of subjects: 39
Study 12028719 — intervention group
Group type: EXPERIMENTAL
Intervention: Time on watch
Number of subjects: 39
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 335
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 335
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 200 mg
Number of subjects: 335
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 300 mg
Number of subjects: 335
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil 50 mg
Number of subjects: 335
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil 100 mg
Number of subjects: 335
Study 10336572 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline beta-adrenoceptor blocker treatment)
Number of subjects: 335
Study 10336572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil (both doses)
Number of subjects: 335
Study 7573719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice a day for 10 days
Number of subjects: 69
Study 7573719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice a day for 14 days
Number of subjects: 69
Study 2007671 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical immunotherapy (diphenylcyclopropenone)
Number of subjects: 139
Study 2007671 — intervention group
Group type: COMPARATOR
Intervention: Control (unilateral treatment side)
Number of subjects: 139
Study 7132464 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental clinics with age-specific checklists and weekly seminars
Number of subjects: 0
Study 7132464 — intervention group
Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 0
Study 30740742 — intervention group
Group type: EXPERIMENTAL
Intervention: SBSP with protocol
Number of subjects: 23
Study 30740742 — intervention group
Group type: COMPARATOR
Intervention: SBSP without protocol
Number of subjects: 23
Study 29654498 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee robusta sachet dissolved in 100 ml of hot water
Number of subjects: 300
Study 29654498 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee arabica (Qahwa)
Number of subjects: 300
Study 29654498 — intervention group
Group type: COMPARATOR
Intervention: 100 ml water only
Number of subjects: 300
Study 27364307 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-cm quilting
Number of subjects: 36
Study 27364307 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-cm quilting
Number of subjects: 36
Study 27364307 — intervention group
Group type: COMPARATOR
Intervention: nonquilting
Number of subjects: 36
Study 24401715 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 52
Study 24401715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 22769066 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based hematoma puncture and partial aspiration in the emergency department followed by craniectomy (Group A)
Number of subjects: 36
Study 22769066 — intervention group
Group type: COMPARATOR
Intervention: Craniectomy only (Group B)
Number of subjects: 36
Study 20035353 — intervention group
Group type: EXPERIMENTAL
Intervention: RAPID protocol (55 patients laparoscopic, 25 patients open)
Number of subjects: 117
Study 20035353 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (15 patients laparoscopic, 22 patients open)
Number of subjects: 117
Study 18672164 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 813
Study 18672164 — intervention group
Group type: COMPARATOR
Intervention: Control (no CRT)
Number of subjects: 813
Study 16160619 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort (900 mg/d)
Number of subjects: 135
Study 14662278 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 7788
Study 14662278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7788
Study 11127574 — intervention group
Group type: EXPERIMENTAL
Intervention: Healon5
Number of subjects: 48
Study 11127574 — intervention group
Group type: COMPARATOR
Intervention: Viscoat
Number of subjects: 48
Study 9176086 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg GTN (0.5 mg/ml)
Number of subjects: 19
Study 9176086 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg GTN (1 mg/ml)
Number of subjects: 19
Study 9176086 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 19
Study 8458531 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil 1200 mg daily for 12 weeks
Number of subjects: 20
Study 8458531 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 3724077 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbimide (50 mg)
Number of subjects: 0
Study 3724077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30832648 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (Resv) combined with Tac
Number of subjects: 0
Study 30832648 — intervention group
Group type: COMPARATOR
Intervention: Tac alone
Number of subjects: 0
Study 30832648 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30117334 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept plus FOLFIRI
Number of subjects: 332
Study 30117334 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus FOLFIRI
Number of subjects: 332
Study 26758193 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized studies
Number of subjects: 146
Study 26758193 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label randomized trials
Number of subjects: 146
Study 26758193 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized studies and open-label randomized trials
Number of subjects: 146
Study 26758193 — intervention group
Group type: COMPARATOR
Intervention: Blinded trials
Number of subjects: 146
Study 26758193 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression to the mean
Number of subjects: 146
Study 26758193 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetrical data handling
Number of subjects: 146
Study 26758193 — intervention group
Group type: EXPERIMENTAL
Intervention: Confounding
Number of subjects: 146
Study 24741684 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CON) protocol
Number of subjects: 0
Study 24741684 — intervention group
Group type: COMPARATOR
Intervention: Eccentric (ECC) protocol
Number of subjects: 0
Study 22339708 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremella mesenterica (Tm) 2 g
Number of subjects: 52
Study 22339708 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremella mesenterica (Tm) with omeprazole 20 mg
Number of subjects: 52
Study 22339708 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1000 mg (standard triple therapy)
Number of subjects: 52
Study 20556775 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled oxygen (at normal pressure)
Number of subjects: 387
Study 20556775 — intervention group
Group type: COMPARATOR
Intervention: Air (control group)
Number of subjects: 387
Study 18052949 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 328
Study 18052949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328
Study 16044078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (4‐6 mg/h)
Number of subjects: 40
Study 16044078 — intervention group
Group type: COMPARATOR
Intervention: Control (without Nicorandil)
Number of subjects: 40
Study 12182991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg q.i.d. for 7 days
Number of subjects: 100
Study 12182991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 10402681 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational thinking style
Number of subjects: 0
Study 10402681 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential thinking style
Number of subjects: 0
Study 8582435 — intervention group
Group type: EXPERIMENTAL
Intervention: etofibrate 500 mg/day for 5 days
Number of subjects: 6
Study 8582435 — intervention group
Group type: COMPARATOR
Intervention: bezafibrate 400 mg/day for 5 days
Number of subjects: 6
Study 2153424 — intervention group
Group type: EXPERIMENTAL
Intervention: R68070 (400 mg)
Number of subjects: 9
Study 2153424 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (400 mg)
Number of subjects: 9
Study 2153424 — intervention group
Group type: COMPARATOR
Intervention: Placebo (400 mg)
Number of subjects: 9
Study 7029741 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amoxycillin and flucloxacillin (Suprapen; Bencard)
Number of subjects: 46
Study 7029741 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics only if postoperative sepsis developed (Control)
Number of subjects: 46
Study 30771559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrate Philly intervention (multi-level intervention including hydration stations, water safety testing, reusable water bottles, and promotion of tap water)
Number of subjects: 28
Study 30771559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrate Philly intervention
Number of subjects: 28
Study 28698331 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using high-viscosity glass ionomer cement
Number of subjects: 240
Study 28698331 — intervention group
Group type: COMPARATOR
Intervention: Composite resin restoration
Number of subjects: 240
Study 28698331 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 240
Study 26488865 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Assisted Thyroidectomy (VAT)
Number of subjects: 33
Study 26488865 — intervention group
Group type: COMPARATOR
Intervention: Conventional Thyroidectomy (CT)
Number of subjects: 33
Study 25189746 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental conditions with varying weights (3 boxes × 14 weights for males, 3 boxes × 9 weights for females)
Number of subjects: 69
Study 25189746 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental conditions with varying weights
Number of subjects: 69
Study 25189746 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' linguistic term for perceived weight
Number of subjects: 69
Study 22641412 — intervention group
Group type: EXPERIMENTAL
Intervention: MALDI-TOF-MS diagnostic model for BD
Number of subjects: 49
Study 19929591 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 40 mg twice daily
Number of subjects: 2760
Study 19929591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2760
Study 17498126 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril (2.5-5 mg)
Number of subjects: 15
Study 17498126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 16177001 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (5 mg oral solution)
Number of subjects: 60
Study 16177001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12079902 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised protocol for measurement of shoulder movements using a gravity inclinometer
Number of subjects: 6
Study 9651408 — intervention group
Group type: EXPERIMENTAL
Intervention: Information from a health professional about the importance of a primary care provider and assistance with making an appointment, continued for up to 3 months after the index ED visit.
Number of subjects: 0
Study 9651408 — intervention group
Group type: EXPERIMENTAL
Intervention: Information from a clerical employee about the importance of a primary care provider and assistance with making an appointment, continued for up to 3 months after the index ED visit.
Number of subjects: 0
Study 9651408 — intervention group
Group type: COMPARATOR
Intervention: No intervention (comparison group).
Number of subjects: 0
Study 7608283 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker bisoprolol (4.25 +/- 1.2 mg/day) for 4 months
Number of subjects: 25
Study 7608283 — intervention group
Group type: COMPARATOR
Intervention: Levothyroxine (L-T4) therapy
Number of subjects: 25
Study 2172309 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-laxative (DL) group
Number of subjects: 100
Study 2172309 — intervention group
Group type: COMPARATOR
Intervention: Control (C) group
Number of subjects: 100
Study 6820492 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 dose of 1500 mg sodium valproate
Number of subjects: 6
Study 6820492 — intervention group
Group type: COMPARATOR
Intervention: 3 doses of 1500 mg sodium valproate
Number of subjects: 6
Study 30406290 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-contour delineation based on a majority vote algorithm (MCD)
Number of subjects: 16
Study 30406290 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus-based delineation (CBD)
Number of subjects: 16
Study 29087863 — intervention group
Group type: EXPERIMENTAL
Intervention: AMT + RELAX
Number of subjects: 58
Study 29087863 — intervention group
Group type: COMPARATOR
Intervention: AMT
Number of subjects: 58
Study 26721141 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing needling manipulation combined with exercise therapy (Group A)
Number of subjects: 64
Study 26721141 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (Group B)
Number of subjects: 64
Study 23795874 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment
Number of subjects: 87
Study 23795874 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine treatment (cocaine users)
Number of subjects: 87
Study 20092916 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 174
Study 20092916 — intervention group
Group type: EXPERIMENTAL
Intervention: Palpation
Number of subjects: 174
Study 20092916 — intervention group
Group type: EXPERIMENTAL
Intervention: Johnson's technique
Number of subjects: 174
Study 20092916 — intervention group
Group type: COMPARATOR
Intervention: Palpation and Johnson's technique
Number of subjects: 174
Study 19157776 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (25mg)
Number of subjects: 20
Study 19157776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19124099 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg iodine/ml (Iopromide 300)
Number of subjects: 71
Study 19124099 — intervention group
Group type: COMPARATOR
Intervention: 400 mg iodine/ml (Iomeprol 400)
Number of subjects: 71
Study 15804728 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hormone therapy (HT)
Number of subjects: 0
Study 12470755 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% once daily
Number of subjects: 165
Study 12470755 — intervention group
Group type: COMPARATOR
Intervention: unoprostone 0.15% twice daily
Number of subjects: 165
Study 9388037 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 73
Study 9388037 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 73
Study 9388037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 7526098 — intervention group
Group type: EXPERIMENTAL
Intervention: STH (streptomycin, thiacetazone, and isoniazid for two months followed by thiacetazone and isoniazid for ten months)
Number of subjects: 191
Study 7526098 — intervention group
Group type: COMPARATOR
Intervention: RHZ (isoniazid, rifampicin, and pyrazinamide for two months followed by isoniazid and rifampicin for seven months)
Number of subjects: 191
Study 7526098 — intervention group
Group type: EXPERIMENTAL
Intervention: STH
Number of subjects: 191
Study 7526098 — intervention group
Group type: COMPARATOR
Intervention: RHZ
Number of subjects: 191
Study 2889957 — intervention group
Group type: EXPERIMENTAL
Intervention: APD (aminohydroxy-propylidene-bisphosphonate), 300 mg daily (n = 70)
Number of subjects: 131
Study 2889957 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 61)
Number of subjects: 131
Study 12207762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead Sea climatotherapy/pseudocatalase cream (PC-KUS)
Number of subjects: 59
Study 12207762 — intervention group
Group type: COMPARATOR
Intervention: Dead Sea climatotherapy alone
Number of subjects: 59
Study 12207762 — intervention group
Group type: COMPARATOR
Intervention: Dead Sea climatotherapy/placebo cream
Number of subjects: 59
Study 12207762 — intervention group
Group type: COMPARATOR
Intervention: Conventional pseudocatalase monotherapy
Number of subjects: 59
Study 12207762 — intervention group
Group type: COMPARATOR
Intervention: Narrowband UVB activated pseudocatalase cream (PC-KUS)
Number of subjects: 59
Study 29659120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for SAD (CBT-SAD)
Number of subjects: 177
Study 29659120 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy (LT)
Number of subjects: 177
Study 27033936 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide releasing solution (NORS)
Number of subjects: 840
Study 27033936 — intervention group
Group type: COMPARATOR
Intervention: Tilmicosin (macrolide antibiotic)
Number of subjects: 840
Study 25193008 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapis judaicus (2g per day for 10 weeks)
Number of subjects: 60
Study 25193008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25193008 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapis judaicus
Number of subjects: 60
Study 22114906 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/hydrochlorothiazide 40/25 mg
Number of subjects: 0
Study 22114906 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan 40 mg
Number of subjects: 0
Study 20300753 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy (methylprednisolone)
Number of subjects: 20